Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)

CompletedOBSERVATIONAL
Enrollment

1,033

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

July 7, 2021

Study Completion Date

September 3, 2021

Conditions
Vaginal Candida
Interventions
DRUG

Clotrimazole 1% (Empecid L Cream, BAYB5097)

Consumers who self-select and are then deemed appropriate users of the product by the pharmacist for treatment of Vulvar itching with rash due to recurrent vaginal candida (only in patients previously diagnosed and treated by a doctor).

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

SATO PHARMACEUTICAL , Ltd.

UNKNOWN

lead

Bayer

INDUSTRY

NCT03599323 - Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%) | Biotech Hunter | Biotech Hunter